Cargando…

Modulation of Hedgehog Signaling for the Treatment of Basal Cell Carcinoma and the Development of Preclinical Models

Basal Cell Carcinoma (BCC) is the most commonly diagnosed cancer worldwide. While the survivability of BCC is high, many patients are excluded from clinically available treatments due to health risks or personal choice. Further, patients with advanced or metastatic disease have severely limited trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dukes, Meghan W., Meade, Thomas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598418/ https://www.ncbi.nlm.nih.gov/pubmed/36289637 http://dx.doi.org/10.3390/biomedicines10102376

Ejemplares similares

Hedgehog signaling pathway and its targets for treatment in basal cell carcinoma
por: Cucchi, Danilo, et al.
Publicado: (2012)

Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity
por: Grund‐Gröschke, Sandra, et al.
Publicado: (2020)

Evaluation of the ‘Hedgehog’ signaling pathways in squamous and basal cell carcinomas of the eyelids and conjunctiva
por: CELEBI, ALI RIZA CENK, et al.
Publicado: (2016)

Expression profile of sonic hedgehog signaling-related molecules in basal cell carcinoma
por: Kim, Hye Sung, et al.
Publicado: (2019)

Activation of the Hedgehog and Wnt/β-Catenin Signaling Pathways in Basal Cell Carcinoma
por: Takada, Tomoaki
Publicado: (2021)

Expression of Hedgehog Signaling Pathway Proteins in Basal Cell Carcinoma: Clinicopathologic Study
por: Deng, Li-Jia, et al.
Publicado: (2022)

Hedgehog Pathway Inhibitors: Clinical Implications and Resistance in the Treatment of Basal Cell Carcinoma
por: Habashy, Suzanne, et al.
Publicado: (2021)

Sonic hedgehog signalling inhibits palatogenesis and arrests tooth development in a mouse model of the nevoid basal cell carcinoma syndrome
por: Cobourne, Martyn T., et al.
Publicado: (2009)

Immunoprevention of Basal Cell Carcinomas with Recombinant Hedgehog-interacting Protein
por: Vogt, Annika, et al.
Publicado: (2004)

Vismodegib hedgehog-signaling inhibition and treatment of basal cell carcinomas as well as keratocystic odontogenic tumors in Gorlin syndrome
por: Booms, Patrick, et al.
Publicado: (2015)

An old friend with new skills: Imiquimod as novel inhibitor of Hedgehog signaling in basal cell carcinoma
por: Gruber, Wolfgang, et al.
Publicado: (2014)

Synergistic cross‐talk of hedgehog and interleukin‐6 signaling drives growth of basal cell carcinoma
por: Sternberg, Christina, et al.
Publicado: (2018)

Advanced basal cell carcinoma, the hedgehog pathway, and treatment options – role of smoothened inhibitors
por: Fecher, Leslie A, et al.
Publicado: (2015)

Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response
por: Gambini, Donatella, et al.
Publicado: (2022)

AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma
por: Yao, Catherine D., et al.
Publicado: (2020)

Effective treatment of locally advanced periocular basal cell carcinoma with oral hedgehog pathway inhibitor?
por: Hou, Xiaoyi, et al.
Publicado: (2020)

Treatment of Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitors: A Multidisciplinary Expert Meeting
por: De Giorgi, Vincenzo, et al.
Publicado: (2021)

A computational study of hedgehog signalling involved in basal cell carcinoma reveals the potential and limitation of combination therapy
por: Buetti-Dinh, Antoine, et al.
Publicado: (2018)

Hedgehog signaling modulates cigarette-induced COPD development
por: Lu, Fang Ying, et al.
Publicado: (2021)

Update on Hedgehog Pathway Inhibitor Therapy for Patients with Basal Cell Naevus Syndrome or High-frequency Basal Cell Carcinoma
por: VERKOUTEREN, Babette J. A., et al.
Publicado: (2022)

Spontaneous resolution of advanced basal cell carcinoma after short-pulse treatment with hedgehog pathway inhibitor
por: Jacobsen, Audrey A., et al.
Publicado: (2016)

Hedgehog signaling pathway: A novel target for cancer therapy: Vismodegib, a promising therapeutic option in treatment of basal cell carcinomas
por: Abidi, Afroz
Publicado: (2014)

Hedgehog signaling promotes basal progenitor expansion and the growth and folding of the neocortex
por: Wang, Lei, et al.
Publicado: (2016)

Polyamine Metabolism as a Therapeutic Target in Hedgehog-Driven Basal Cell Carcinoma and Medulloblastoma
por: Coni, Sonia, et al.
Publicado: (2019)

Hedgehog target genes regulate lipid metabolism to drive basal cell carcinoma and medulloblastoma
por: Daggubati, Vikas, et al.
Publicado: (2023)

Long-Noncoding RNA ANCR Activates the Hedgehog Signaling Pathway to Promote Basal Cell Carcinoma Progression by Binding to PTCH
por: Wu, Hongxuan, et al.
Publicado: (2022)

Hedgehog signaling regulates the development and treatment of glioblastoma
por: Wang, Hongping, et al.
Publicado: (2022)

Vismodegib: First-in-Class Hedgehog Pathway Inhibitor for Metastatic or Locally Advanced Basal Cell Carcinoma
por: Nix, Nancy M., et al.
Publicado: (2014)

Hedgehog Pathway Inhibitors and Their Utility in Basal Cell Carcinoma: A Comprehensive Review of Current Evidence
por: Tay, Evelyn Yu-Xin, et al.
Publicado: (2018)

Qualitative Patient Interviews to Characterize the Human Burden of Advanced Basal Cell Carcinoma Following Hedgehog Pathway Inhibitor Treatment
por: Konidaris, Gerasimos, et al.
Publicado: (2023)

Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib
por: Hehlgans, Stephanie, et al.
Publicado: (2018)

Roughing up Smoothened: chemical modulators of Hedgehog signaling
por: King, Randall W
Publicado: (2002)

WIP1 modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastoma
por: Wen, Jing, et al.
Publicado: (2016)

Analysis of the occurrence and distribution of primary and recurrent basal cell carcinoma of head and neck coupled to the assessment of tumor microenvironment and Sonic hedgehog signaling
por: Moisejenko-Golubovica, Jelena, et al.
Publicado: (2020)

Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
por: Lacouture, Mario E., et al.
Publicado: (2016)

Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma
por: Doan, Hung Q., et al.
Publicado: (2021)

Using drug scheduling to manage adverse events associated with hedgehog pathway inhibitors for basal cell carcinoma
por: Lear, John T., et al.
Publicado: (2021)

Real-World Treatment Patterns and Outcomes Among Patients with Basal Cell Carcinoma Following First-Line Hedgehog Inhibitor Discontinuation
por: Cowey, Lance, et al.
Publicado: (2022)

Happle–Tinschert, Curry–Jones and segmental basal cell naevus syndromes, overlapping disorders caused by somatic mutations in hedgehog signalling genes: the mosaic hedgehog spectrum
por: Lovgren, M.‐L., et al.
Publicado: (2019)

Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts?
por: Eibenschutz, Laura, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_srmc2ltepi4fdov1mbesn21erv